果胶铋联合阿莫西林治疗慢性萎缩性胃炎临床疗效分析.docVIP

精品论文 参考文献 果胶铋联合阿莫西林治疗慢性萎缩性胃炎临床疗效分析 杜岗 　　遂宁市船山区龙凤中心卫生院 四川 遂宁629000 　　摘要 目的探讨采用果胶铋联合阿莫西林治疗慢性萎缩性胃炎的方法和临床效果。方法选择我院2014年6月~2015年7月接收的慢性萎缩性胃炎患者96位作为此次研究对象，随机分为两组即对照组与观察组。对照组48例患者使用阿莫西林单独治疗，观察组48例患者则接受果胶铋联合阿莫西林联合治疗。对两组患者的病情恢复状况、治疗时间、感染复发率、不良反应发生率等指标进行比较观察。结果观察组患者治疗时间、感染复发率、不良反应发生率大大降低，差异具有统计学意（plt;0.05）；观察组患者恢复情况明显改善，总体有效率明显高于对照组，差异具有统计学意义（plt;0.05）。结论采用果胶铋联合阿莫西林治疗慢性萎缩性胃炎效果显著、安全性好，可明显改善患者病情，降低患者感染复发几率，临床上值得继续推广。 　　关键词：果胶铋；阿莫西林；慢性萎缩性胃炎；临床效果 　　Objective to explore the pectic bismuth joint amoxicillin method and clinical effect for the treatment of chronic atrophic gastritis. Methods from June 2014 to July 2015 received 96 patients with chronic atrophic gastritis as the research object, were randomly divided into two groups namely the control group and observation group. The control group of 48 patients with amoxicillin therapy alone, observation group of 48 patients received pectic bismuth joint amoxicillin combined treatment. On the condition of two groups of patients recovery, treatment time, infection recurrence rate, incidence of adverse reactions such as index to compare observation. Results observation group of patients treatment time, infection rate of relapse, and greatly reduce the incidence of adverse reactions, the difference has statistics meaning (p lt; 0.05); Observation group of patients obviously improved recovery, the overall effectiveness is significantly higher than the control group, difference has statistical significance (p lt; 0.05). Conclusion treatment of chronic atrophic gastritis using pectic bismuth joint amoxicillin effect is remarkable, security is good, can obviously improve the patient condition, reduce the recurrence of infection in patients with risk, clinically worth to promote. 　　Key words: pectic bismuth; Amoxicillin. Chronic atrophic gastritis; Clinical effect 　　慢性萎缩性胃炎，发病机制为胃黏膜变薄，腺体萎缩且减少，临床表现胃胀痛、嗳气，食欲不振或消瘦，不消化。是常见的慢性消化系统疾病，诱发因素较多和患者的生活饮食习惯还有工作有关[1]。此类病需及时发现及时治疗，若治疗不及时则存在出血、穿孔甚至后期引发癌变的可能，此外病情通常会在进食后加重。目前临床上治疗药物有阿莫西林、克拉霉素、果胶铋［2］。本文选择我院消化